Discussion of NSABB’s publication recommendations for the NIH-funded research on the transmissibility of H5N1

Wednesday, February 29, 2012 | 7:15 a.m. – 8:15 a.m.                                                                                                                                                        (Link available Feb.29th)

Moderated by the Chair of the National Science Advisory Board for Biosecurity (NSABB), Paul Keim, Ph.D., this newly added session at the ASM Biodefense and Emerging Diseases Research Meeting will include discussions of the NSABB’s recommendations for the publication of the controversial H5N1 research. This session will also provide an open forum for attendees to give their feedback on such policy issues as the appropriate mechanisms to allay public concerns about the safety of dual use research.

Presentations will include:

NSABB Recommendations

Michael T. Osterholm, Ph.D., MPH
University of Minnesota School of Public Health, Minneapolis, MN
Director, Center for Infectious Disease Research and Policy (CIDRAP)

Government Response to the Recommendations

Anthony S. Fauci, M.D.
Director, National Institute of Allergy and Infectious Diseases (NIAID)

Science’s Response to the Situation

Bruce Alberts, Ph.D.
Editor-in-Chief of Science

Perspective from an Investigator

Ron A.M. Fouchier, Ph.D.
Erasmus MC, Rotterdam, Netherlands